Literature DB >> 17786390

Graft failure: II. Ocular surface complications.

Samar A Al-Swailem1.   

Abstract

Risk factors for corneal transplantation failure include both immunologic factors, such as graft rejection, corneal neovascularization, and peripheral anterior synechiae, as well as non-immunologic factors, such as ocular surface disorders (OSD) and glaucoma. This review highlights the necessity of having healthy ocular surface epithelia, tears, and eyelids. It presents different types of OSD, their underlying pathology, and their impact on native cornea and corneal grafts. In addition, a range of proposed donor and surgical factors influencing surface integrity following corneal transplant are addressed. Current medical and surgical research, both pre- and post-operative that promise to further improve the outcome of corneal grafts in the context of OSD are discussed.

Entities:  

Mesh:

Year:  2008        PMID: 17786390     DOI: 10.1007/s10792-007-9127-9

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  155 in total

Review 1.  The ocular surface and tear film and their dysfunction in dry eye disease.

Authors:  M Rolando; M Zierhut
Journal:  Surv Ophthalmol       Date:  2001-03       Impact factor: 6.048

2.  Gas-permeable scleral contact lens therapy in ocular surface disease.

Authors:  T Romero-Rangel; P Stavrou; J Cotter; P Rosenthal; S Baltatzis; C S Foster
Journal:  Am J Ophthalmol       Date:  2000-07       Impact factor: 5.258

3.  Living related conjunctival limbal allograft for the treatment of stem cell deficiency.

Authors:  S M Daya; F A Ilari
Journal:  Ophthalmology       Date:  2001-01       Impact factor: 12.079

4.  The survival and rejection of epithelium in experimental corneal transplants.

Authors:  A A Khodadoust; A M Silverstein
Journal:  Invest Ophthalmol       Date:  1969-04

5.  Impact of short-term versus long-term topical steroids on corneal neovascularization after non-high-risk keratoplasty.

Authors:  C Cursiefen; H Wenkel; P Martus; A Langenbucher; N X Nguyen; B Seitz; M Küchle; G O Naumann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2001-07       Impact factor: 3.117

6.  The clinical efficacy of silicone punctal plug therapy.

Authors:  Ming-Cheng Tai; C Banu Cosar; Elisabeth J Cohen; Christopher J Rapuano; Peter R Laibson
Journal:  Cornea       Date:  2002-03       Impact factor: 2.651

Review 7.  Management of conjunctival cicatrizing diseases and severe ocular surface dysfunction.

Authors:  A G Chiou; G J Florakis; M Kazim
Journal:  Surv Ophthalmol       Date:  1998 Jul-Aug       Impact factor: 6.048

8.  Antiviral therapy after penetrating keratoplasty for herpes simplex keratitis.

Authors:  A L Moyes; A Sugar; D C Musch; R D Barnes
Journal:  Arch Ophthalmol       Date:  1994-05

9.  Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group.

Authors:  M G Maguire; W J Stark; J D Gottsch; R D Stulting; A Sugar; N E Fink; A Schwartz
Journal:  Ophthalmology       Date:  1994-09       Impact factor: 12.079

10.  A randomized trial of pressure patching for epithelial defects after keratoplasty.

Authors:  A Sugar; R F Meyer; C F Bahn
Journal:  Am J Ophthalmol       Date:  1983-05       Impact factor: 5.258

View more
  2 in total

1.  Corticosteroid-loaded biodegradable nanoparticles for prevention of corneal allograft rejection in rats.

Authors:  Qing Pan; Qingguo Xu; Nicholas J Boylan; Nicholas W Lamb; David G Emmert; Jeh-Chang Yang; Li Tang; Tom Heflin; Saeed Alwadani; Charles G Eberhart; Walter J Stark; Justin Hanes
Journal:  J Control Release       Date:  2015-01-08       Impact factor: 9.776

Review 2.  The Emerging Role of Nanotechnology in Cell and Organ Transplantation.

Authors:  Ennio Tasciotti; Fernando J Cabrera; Michael Evangelopoulos; Jonathan O Martinez; Usha R Thekkedath; Malgorzata Kloc; Rafik M Ghobrial; Xian C Li; Alessandro Grattoni; Mauro Ferrari
Journal:  Transplantation       Date:  2016-08       Impact factor: 4.939

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.